Education
About Us
Working with TipRanks
Follow Us
Schrodinger (SDGR)
NASDAQ:SDGR
SDGR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$16.67 - $29.15
Previous CloseN/A
Volume166.74K
Average Volume (3M)1.02M
Market Cap
$1.57B
Enterprise Value$1.07B
Total Cash (Recent Filing)$147.33M
Total Debt (Recent Filing)$117.83M
Price to Earnings (P/E)―
Beta2.34
Next Earnings
Apr 30, 2025EPS Estimate
-0.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.58
Shares Outstanding63,874,200
10 Day Avg. Volume907,234
30 Day Avg. Volume1,022,697
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.67
Price to Cash Flow (P/CF)-12.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.68
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.12
Enterprise Value/Ebitda-5.28
Forecast
1Y Price Target
$31.63Price Target Upside47.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
Schrodinger News
PremiumCompany Announcements
Schrödinger, Inc. Reports Mixed Earnings Call Results
PremiumCompany Announcements
Schrödinger, Inc. Reports Strong 2024 Financial Results
---
Bulls Say, Bears Say
Bulls Say
Customer RetentionCustomer retention rate among high-value customers was 100%, and the number of such customers increased from 54 to 61.
Growth ProspectsOptimism remains for further large collaboration announcements as more biopharma companies follow NVS's playbook.
PartnershipsAn expanded research collaboration with LLY builds on a previous collaboration, indicating strengthened partnerships.
Revenue Growth4Q24 software revenue increased 16.0% year-over-year due to increased hosted revenue from large customers.
Bears Say
Cost ManagementSoftware gross margin decreased to 83% due to higher cost of revenue associated with the predictive toxicology initiative.
Revenue ExpectationsQ3 revenues were lower than consensus estimates primarily due to lower than anticipated software contribution.
---
Ownership Overview
2.24% Insiders
20.18% Mutual Funds
41.73% Other Institutional Investors
9.80% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SDGR FAQ
What was Schrodinger’s price range in the past 12 months?
Schrodinger lowest stock price was $16.67 and its highest was $29.15 in the past 12 months.
What is Schrodinger’s market cap?
Schrodinger’s market cap is $1.57B.
When is Schrodinger’s upcoming earnings report date?
Schrodinger’s upcoming earnings report date is Apr 30, 2025 which is in 34 days.
How were Schrodinger’s earnings last quarter?
Schrodinger released its earnings results on Feb 26, 2025. The company reported -$0.55 earnings per share for the quarter, missing the consensus estimate of -$0.424 by -$0.126.
Is Schrodinger overvalued?
According to Wall Street analysts Schrodinger’s price is currently Undervalued.
Does Schrodinger pay dividends?
Schrodinger does not currently pay dividends.
What is Schrodinger’s EPS estimate?
Schrodinger’s EPS estimate is -0.74.
How many shares outstanding does Schrodinger have?
Schrodinger has 63,874,200 shares outstanding.
What happened to Schrodinger’s price movement after its last earnings report?
Schrodinger reported an EPS of -$0.55 in its last earnings report, missing expectations of -$0.424. Following the earnings report the stock price went up 2.535%.
Which hedge fund is a major shareholder of Schrodinger?
Currently, no hedge funds are holding shares in SDGR
---
Schrodinger Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.63 (47.46% Upside)
$31.63 (47.46% Upside)
Blogger Sentiment
Bullish
SDGR Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 127.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 8.8%
Last 30 Days ▼ 8.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.91%
12-Months-Change
Fundamentals
Return on Equity
-38.58%
Trailing 12-Months
Asset Growth
2.52%
Trailing 12-Months
Company Description
Schrodinger
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
---
SDGR Company Deck
---
SDGR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant growth in software revenue and strategic collaborations, indicating positive operational momentum. However, the company faced challenges with increased operating losses and a decline in drug discovery revenue. While the progress in clinical programs and high customer retention are promising, financial strains and increased costs present challenges.Read More>---
SDGR Stock 12 Month Forecast
Average Price Target
$31.63
▲(47.46% Upside)
Technical Analysis
Qiagen
―
Vertex Pharmaceuticals
―
Blueprint Medicines
―
Denali Therapeutics
―
Recursion Pharmaceuticals
―
Best Analysts Covering SDGR
1 Year
1 Year Success Rate
9/19 ratings generated profit
1 Year Average Return
-8.27%
reiterated a buy rating 28 days ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 47.37% of your transactions generating a profit, with an average return of -8.27% per trade.
---